486
Participants
Start Date
February 2, 2016
Primary Completion Date
September 14, 2017
Study Completion Date
September 14, 2017
Tafenoquine 150 mg
Tablet contains TQ as tafenoquine succinate. The 2 tablets (2 tablets of 150mg) of dark pink, capsule-shaped, film coated will be administered orally with 240ml of water.
Matched placebo 150mg
It is the matched Placebo tablet. The 2 tablets (2 tablets of 150mg) of dark pink, capsule-shaped, film coated will be administered orally with 240ml of water.
GSK Investigational Site, Baltimore
GSK Investigational Site, Overland Park
GSK Investigational Site, Glendale
Lead Sponsor
Medicines for Malaria Venture
OTHER
GlaxoSmithKline
INDUSTRY